Related Experiment Videos
Factor VIII inhibitor assay using skin puncture blood samples
R F Hinchliffe1, G J Bellamy, J S Lilleyman
1Department of Haematology, Children's Hospital, Western Bank, Sheffield.
Journal of Clinical Pathology
|May 1, 1990
Summary
A new method measures factor VIII inhibitors using minimal skin puncture blood. This technique shows high correlation with traditional venous sampling, offering a valuable alternative for monitoring haemophilia patients.
Area of Science:
- Hematology
- Clinical Chemistry
Background:
- Factor VIII inhibitors are critical complications in hemophilia management.
- Accurate and accessible monitoring of inhibitor levels is essential for treatment efficacy.
Purpose of the Study:
- To develop and validate a novel method for measuring factor VIII inhibitors using small-volume skin puncture blood.
- To assess the feasibility and reliability of this technique compared to conventional venous blood sampling.
Main Methods:
- A modified Bethesda technique was employed for factor VIII inhibitor quantification.
- Paired skin puncture and venous blood samples were collected from human and porcine subjects.
- Assays were performed on inhibitor-positive and inhibitor-negative hemophilia patient samples.
Main Results:
- High correlation was observed between factor VIII inhibitor concentrations measured in skin puncture and venous blood samples.
- No significant differences were found between the two sampling methods across multiple assays.
- The skin puncture method demonstrated reliability in detecting inhibitors in hemophilia patients.
Conclusions:
- Skin puncture blood offers a viable alternative for factor VIII inhibitor measurement using the Bethesda technique.
- This method is particularly useful for monitoring higher inhibitor concentrations when venous access is challenging.
- The technique provides a less invasive option for routine monitoring in hemophilia care.